The importance of adjuvant formulation in the development of a TB vaccine

od Baldwin, Susan L., Bertholet, Sylvie, Reese, Valerie A., Ching, Lance K., Reed, Steven G., Coler, Rhea N.
Wydane 2012

The ID93 Tuberculosis Vaccine Candidate Does Not Induce Sensitivity to Purified Protein Derivative

od Baldwin, Susan L., Reese, Valerie, Granger, Brian, Orr, Mark T., Ireton, Gregory C., Coler, Rhea N., Reed, Steven G.
Wydane 2014

Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate

od Baldwin, Susan L., Reese, Valerie A., Huang, Po-wei D., Beebe, Elyse A., Podell, Brendan K., Reed, Steven G., Coler, Rhea N.
Wydane w Clin Vaccine Immunol (2016)

Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis()

od Orr, Mark T., Ireton, Gregory C., Beebe, Elyse A., Huang, Po-Wei D., Reese, Valerie A., Argilla, David, Coler, Rhea N., Reed, Steven G.
Wydane 2014

Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4(+) T-Cell Responses for Vaccine Control of Tuberculosis

od Orr, Mark T., Windish, Hillarie Plessner, Beebe, Elyse A., Argilla, David, Huang, Po-Wei D., Reese, Valerie A., Reed, Steven G., Coler, Rhea N.
Wydane w J Infect Dis (2015)

Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment

od Larsen, Sasha E., Baldwin, Susan L., Orr, Mark T., Reese, Valerie A., Pecor, Tiffany, Granger, Brian, Dubois Cauwelaert, Natasha, Podell, Brendan K., Coler, Rhea N.
Wydane w Vaccines (Basel) (2018)

Examining the Effectiveness of Provider Incentives to Increase CRC Screening Uptake in Neighborhood Healthcare: A California Federally Qualified Health Center

od Barajas, Melissa, Tangka, Florence K. L., Schultz, James, Tantod, Kulin, Kempster, Ying Marilyn, Omelu, Ndukaku, Hoover, Sonja, Thomas, Melonie, Richmond-Reese, Valerie, Subramanian, Sujha
Wydane w Health Promot Pract (2020)

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model

od Baldwin, Susan L., Reese, Valerie A., Larsen, Sasha E., Beebe, Elyse, Guderian, Jeff, Orr, Mark T., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Wydane w PLoS One (2021)

Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic Treatment

od Coler, Rhea N., Bertholet, Sylvie, Pine, Samuel O., Orr, Mark T., Reese, Valerie, Windish, Hillarie Plessner, Davis, Charles, Kahn, Maria, Baldwin, Susan L., Reed, Steven G.
Wydane 2013

Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic T(H)1 to tissue-resident T(H)17 responses without impacting the protective efficacy(§)

od Orr, Mark T., Beebe, Elyse A., Hudson, Thomas, Argilla, David, Huang, Po-Wei D., Reese, Valerie A., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Wydane w Vaccine (2015)

Economic Assessment of Patient Navigation to Colonoscopy-Based Colorectal Cancer Screening in the Real-World Setting at the University of Chicago Medical Center

od Kim, Karen E., Randal, Fornessa, Johnson, Matt, Quinn, Michael, Maene, Chieko, Hoover, Sonja, Richmond-Reese, Valerie, Tangka, Florence K. L., Joseph, Djenaba A., Subramanian, Sujha
Wydane w Cancer (2018)

Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models

od Larsen, Sasha E., Reese, Valerie A., Pecor, Tiffany, Berube, Bryan J., Cooper, Sarah K., Brewer, Guy, Ordway, Diane, Henao-Tamayo, Marcela, Podell, Brendan K., Baldwin, Susan L., Coler, Rhea N.
Wydane w Sci Rep (2021)

Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29

od Carrigy, Nicholas B., Larsen, Sasha E., Reese, Valerie, Pecor, Tiffany, Harrison, Melissa, Kuehl, Philip J., Hatfull, Graham F., Sauvageau, Dominic, Baldwin, Susan L., Finlay, Warren H., Coler, Rhea N., Vehring, Reinhard
Wydane w Antimicrob Agents Chemother (2019)